EPISODE · Dec 1, 2020 · 12 MIN
MusclePharm Kicks Profitability Haters Straight in the Face!
from the Joshua Schall Audio Experience · host Joshua Schall
In this latest podcast episode, I'll breakdown the most important key quarter-end financial data from the recent MusclePharm Corporation (MSLP) 2020Q1 through 2020Q3 earnings reports that were released on 11/24/2020. I'll explain why the sports nutrition brand filed a clustering of quarterly financial reports again (Note: they are not caught up to SEC disclosure requirements). Additionally, I'll update you on MusclePharm important events through a collection of publicly-disclosed news and cover a variety of risk footnotes that were in the latest set of 10-Q filings. Finally, I'll answer the cliffhanger question from the previous piece of content surrounding if MusclePharm would finally reach its goal of being profitable in 2020.
What this episode covers
In this latest podcast episode, I'll breakdown the most important key quarter-end financial data from the recent MusclePharm Corporation (MSLP) 2020Q1 through 2020Q3 earnings reports that were released on 11/24/2020. I'll explain why the sports nutrition brand filed a clustering of quarterly financial reports again (Note: they are not caught up to SEC disclosure requirements). Additionally, I'll update you on MusclePharm important events through a collection of publicly-disclosed news and cover a variety of risk footnotes that were in the latest set of 10-Q filings. Finally, I'll answer the cliffhanger question from the previous piece of content surrounding if MusclePharm would finally reach its goal of being profitable in 2020.
NOW PLAYING
MusclePharm Kicks Profitability Haters Straight in the Face!
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m